Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rat immunoreactive cholecystokinin (CCK): characterization using two chromatographic techniques.

A J Bacarese-Hamilton, T E Adrian, P Chohan

    Regulatory Peptides
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Out of our comfort zone.

    British dental journal·2020
    Same author

    The provision of surgical tracheostomies by maxillofacial surgeons in the UK: time for a dedicated tracheostomy team?

    Annals of the Royal College of Surgeons of England·2017
    Same author

    Case detection of disease by NHS Health Checks in Warwickshire, England and comparison with predicted performance.

    Public health·2014
    Same author

    The effects of various peptides on human isolated gut muscle.

    The Journal of pharmacy and pharmacology·1992
    Same author

    The presence, characterisation and synthesis of neuromedin B in the human pituitary gland.

    Neuroendocrinology·1992
    Same author

    Expression of messenger ribonucleic acids encoding neuropeptide-Y, substance-P, and vasoactive intestinal polypeptide in human pituitary.

    The Journal of clinical endocrinology and metabolism·1992

    Rat brain and small intestine exhibit distinct cholecystokinin processing. The brain primarily contains sulfated cholecystokinin-8 (CCK-8), while the gut has larger, less processed CCK forms, indicating tissue-specific post-translational cleavage.

    Area of Science:

    • Neuroscience
    • Gastroenterology
    • Biochemistry

    Background:

    • Cholecystokinin (CCK) is a peptide hormone with diverse physiological roles in the brain and gut.
    • Understanding the molecular forms of CCK is crucial for elucidating its function.
    • Previous studies have suggested variations in CCK processing, but detailed characterization in different rat tissues is needed.

    Purpose of the Study:

    • To quantify and characterize the endogenous molecular forms of cholecystokinin-like immunoreactivity (CCK-LI) in rat cerebral cortex and upper small intestine.
    • To compare the extraction properties and molecular size of CCK-LI in these two distinct tissues.

    Main Methods:

    • Preparation of acid and neutral extracts from rat cerebral cortex and upper small intestine.
    • Quantification of CCK-LI using three novel CCK-specific radioimmunoassays.

    Related Experiment Videos

  • Molecular form characterization via gel permeation chromatography (in 6 M urea) and reverse-phase high-performance liquid chromatography (HPLC).
  • Main Results:

    • Rat cortex exhibited high CCK-LI concentrations (268 ± 12 pmol/g), predominantly as sulfated CCK-8 (over 90%), preferentially extracted at neutral pH.
    • Rat upper small intestine showed lower CCK-LI (97 ± 8 pmol/g), with less than 20% CCK-8. The majority were larger molecular forms, preferentially extracted at acid pH.
    • The predominant CCK forms in the small intestine were intermediate in size between CCK-33 and CCK-8, with significant amounts of CCK-33 and larger forms also detected.

    Conclusions:

    • Post-translational cleavage and processing of cholecystokinin differ significantly between the rat brain and small intestine.
    • The brain primarily utilizes the smaller, sulfated CCK-8 form, while the gut processes CCK into larger molecular weight forms.
    • These findings highlight tissue-specific regulation of CCK peptide processing.